Hiroaki Miyata

The University of Tokyo

Papers

1

Total Citations

10

H-Index

1

About

Hiroaki Miyata is a leading figure in surgical outcomes research, with a focus on advancing minimally invasive techniques for esophageal cancer treatment. His work centers on evaluating the comparative effectiveness of robot-assisted versus conventional surgical approaches, leveraging large-scale nationwide databases to provide robust, real-world evidence. In his landmark 2024 study, Miyata employed rigorous propensity score matching to analyze short-term outcomes from a national dataset, demonstrating that robot-assisted minimally invasive esophagectomy offers measurable advantages over conventional methods. This research, already garnering 10 citations shortly after publication, has significant implications for surgical decision-making and patient care. Miyata’s contributions are distinguished by his commitment to methodological rigor—using advanced statistical techniques to minimize bias in observational studies—and his ability to translate big data into actionable clinical insights. His work not only informs surgical practice but also sets a standard for evidence-based evaluation of emerging technologies, making him a key voice in the ongoing evolution of esophageal cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Short‐term outcomes of robot‐assisted versus conventional minimally invasive esophagectomy: A propensity score‐matched study via a nationwide database
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: The University of Tokyo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago